Natera on Thursday said the United States District Court for the District of Delaware has ordered an ongoing 30% royalty on certain post-injunction sales tied to its long-running ...
InvestorsHub on MSN
Court orders 30% ongoing royalty for Natera in patent dispute
Natera Inc. (NASDAQ:NTRA) said a federal court in Delaware has ruled that the company is entitled to a 30% ongoing royalty on ...
Natera (NTRA) has moved into focus after a favorable patent ruling against ArcherDx and Invitae, royalty income tied to MRD products, broad uptake of its Signatera test, and recent progress toward ...
This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts ...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today provided an update on a recent ...
Natera Inc. NTRA shares rose slightly in premarket trading after a Delaware court awarded the company a 30% ongoing royalty ...
14d
Estee Lauder
Get all latest & breaking news on Estee Lauder. Watch videos, top stories and articles on Estee Lauder at moneycontrol.com.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results